[1]
2025. Artificial Intelligence Generated Molecules Entering Trials: Provenance, Novelty and Attribution. Translational Medicine & Therapeutics Journal. 4, 2 (Jul. 2025), 55–63. DOI:https://doi.org/10.5281/zenodo.22649409.